Rat Model Market revenue to hit $1.8 billion by 2025: Global Market Insights, Inc.

Rat Model Market value is projected to register around 8% CAGR up to 2025, impelled by increase in the number of research and development activities in pharma/biotech companies.


Selbyville, Delaware, Dec. 05, 2019 (GLOBE NEWSWIRE) --

Global Rat Model Market value is set to surpass USD 1.8 billion by 2025, according to a new research report by Global Market Insights, Inc. Growing usage of rat models in the development of novel vaccines and increase in the adoption of rat models for conducting various research studies on diseases such as autoimmune diseases, cancer, cardiovascular diseases are some of the factors that will majorly drive the rat model industry growth over the projected timeframe. 

Rat model is defined as the use of animals to study the development and advancement of diseases since there are various similarities between humans and rats. The upsurge of rat models in biological research studies coupled with functional resemblances of rats to human body are few factors boosting the market growth in the upcoming years. Growing number of animal testing procedures for ensuring drug safety and regular use of rat model in animal testing owing to its genetic similarities with humans are also few factors that are offering significant traction to the market growth. Rats are one of the animals that are widely used in the medical research since they are the primary model for mechanistic studies of human reproduction.  Hence, all these factors are expected to boost the adoption of rat models across the globe and is further projected to boost the market growth in the upcoming years.         

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/4165

On the basis of rat type, the rat model market is segmented as inbred, outbred, knockout, hybrid and others. The inbred rat model business held the maximum share of over 25.0% in 2018. Upsurge of rat models in autoimmune disorder research is rapidly increasing as rat models can mimic autoimmune diseases that affect humans and these models offer a large scale of tissue samples than mice models. These factors further assist researchers to understand the mechanism of diseases that will further play a significant role in propelling the global market growth in the near future.

Some major findings of the rat model market statistics report include:

  • Increase in number of rat models for use in cognitive research, growing development of new medical devices and assessing the safety and efficacy of new drugs will act as high impacting factors for rat model market growth
  • Growing demand for personalized humanized rat models owing to increasing consumption of personalized medicines, and expanding applications of rat model in drug discovery including target identification, validation, new therapeutic strategies will further propel the growth of the market in future
  • Major industry players in the rat model industry include Envigo, genOway, Charles River, Horizon Discovery Group plc, Biomere, Transviragen Inc., Janvier Labs, Taconic Biosciences Inc. and Transpogen Biopharmaceutical, Inc.
  • Growing activities of discovery and development of new medicines and ongoing research activities on understanding the autoimmune diseases in rats are some of the factors that are boosting the market growth

Based on technology, the rat model market is segmented into CRISPR, microinjection, embryonic stem cell, nuclear transfer and others. The CRISPR technology market accounted for 31.5% market share in 2018. Rapid growth of CRISPR technology is owing to certain advantages such as ease of use, cost-effectiveness, time saving, and greater efficiency required to alter target genes compared to other gene targeting technologies. Hence, the above-mentioned advantages enhance the demand and adoption of CRISPR technology in rat model industry, thereby boosting the business growth.

Browse key industry insights spread across 450 pages with 376 market data tables & 11 figures & charts from the report, “Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production And Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Switzerland, Netherlands, Czech Republic, Poland, Belgium, Finland, Hungary, Denmark, Ireland, Sweden, China, Japan, Australia, South Korea, New Zealand, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Israel), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/rat-model-market

On the basis of application, the market is segment into research & development, production and quality control, academics and others. The research and development segment held the largest revenue share at around 72.2% in the year 2018. The demand of rat models for research and development is in order to check the cognitive function that rats and humans share. Since rats are able to remember wider variety of tasks, it in turn helps the researchers to perform several studies on rats about memory and learning. Hence, such factors are responsible for boosting the rat model market growth for research and development.

On the basis of use, rat model is segmented into human and veterinary. The use of animal model for humans held the highest market share of over 80% in the year 2018. Rise in testing procedures on rats for understanding of diseases such as cardiovascular diseases and diabetes among others that can harm humans is propelling the market growth. Furthermore, increase in the number of rat models for understanding the biological behavior of diseases such as cardiovascular diseases, autoimmune diseases and cancer are few factors that are expected to impel the segmental growth.

On the basis of end-use, rat model industry is segmented into companies, organizations, academic & research institutes and contract research organizations. Companies held the highest market share of over 61.2% in the year 2018. Growing number of research & development activities in the biotech and pharma industry that demands for animal testing for confirming the efficacy and safety of drugs along with the development of novel vaccines are propelling the segmental growth.

The U.S. rat model market is estimated to expand at more than 8.0% CAGR over the projected period. As per the American Burn Association, around 486,000 people were reported at emergency departments for burn/fire injuries. Therefore, various research institutes in the country are conducting physiological tests that rats and humans share in order to mimic the human skin structure. Hence, owing to this, the demand for rat model will significantly escalate in the near future.

Key players are executing several growth strategies such as acquisitions and mergers in order to increase their geographic presence and their product portfolio. For instance, in April 2019, Charles River Laboratories completed the acquisition of Citoxlab. The acquisition would lead to important expansion of the treatment option, thereby resulting in better quality of life. It will further bolster the company’s global position by expanding its scientific product portfolio, that will in turn enhance their client partner relations across the drug discovery and development continuum.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/4165

Browse Related Reports:

Animal Model Market Analysis Report 2025: On the basis of animal type, the animal model market is segmented as mice, rats, fish, birds, cattle, pigs, amphibians, rabbits, guinea pigs, dogs, cats, sheep, hamsters, monkeys, and others. The mice market held the maximum share of over 51.7% and was valued at around USD 7 billion in the year 2018. The upsurge of mice models in cancer research is burgeoning owing to low-cost factors and widespread availability. Some of the prominent industry players include Charles River, Envigo, genOway, Horizon Discovery Group Plc, Harbour BioMed, Taconic Biosciences, Inc., Janvier Labs, The Jackson Laboratory and TRANS GENIC Inc, Ltd.    

https://www.gminsights.com/industry-analysis/animal-model-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


            

Coordonnées